LAROTRECTINIB

587 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAROTRECTINIB:

# Side effect Count
0 DRUG INEFFECTIVE 39
1 DIZZINESS 37
2 FATIGUE 36
3 PAIN 34
4 NEUROPATHY PERIPHERAL 24
5 OFF LABEL USE 24
6 DEATH 23
7 NAUSEA 23
8 DISEASE PROGRESSION 19
9 MYALGIA 16
See all common reactions for LAROTRECTINIB

LAROTRECTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FIBROSARCOMA METASTATIC 1 0.1667
1 ADENOCARCINOMA OF SALIVARY GLAND 2 0.0714
2 CEREBRAL MICROINFARCTION 1 0.0476
3 BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC 1 0.0357
4 DESMOPLASTIC SMALL ROUND CELL TUMOUR 2 0.0286
5 MALIGNANT GLIOMA 3 0.0273
6 CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS 1 0.0270
7 ASSISTED SUICIDE 1 0.0256
8 GLIONEURONAL TUMOUR 1 0.0217
9 ADENOID CYSTIC CARCINOMA 2 0.0183
See all enriched reactions for LAROTRECTINIB